MNPR logo

Monopar Therapeutics Inc. (MNPR)

Profile

Full Name

Monopar Therapeutics Inc.

Ticker

NASDAQ: MNPR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 19, 2019

Indexes

Not included

Website

https://www.monopartx.com

Employees

14

Key Details

Price

$32.06(+0.69%)

Market cap

$197.81M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$4.11(-34.75% YoY)

PE ratio

-

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $32.06
    MNPR price is $32.06

    30-Day Relative Volume

    2.12
    MNPR 30-day relative volume is 2.12

    Price Performance

    Price Most recent change

    +0.69%
    MNPR price was up +0.69% on Aug 22, 2025

    Price YTD change

    +45.73%
    MNPR price is up +45.73% since January 1st

    Price 1-year change

    +1061.59%
    MNPR price is up +1061.59% year-on-year

    Price 3-year change

    +256.22%
    MNPR price is up +256.22% over the past 3 years

    Price Range

    Price All-time high

    $240.00
    MNPR price is currently -86.64% below its historical high of $240.00

    Price 3-year low

    $1.37
    MNPR price is currently +2240.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $197.81M
    MNPR market capitalization is $197.81 million

    Market cap 3-year change

    +763.54%
    MNPR market capitalization is up +763.54% over the past 3 years

    Market cap All-time high

    $316.66M
    MNPR market capitalization is currently -37.53% below its historical high of $316.66 million

    Market cap sector rank

    50.79%
    MNPR market capitalization is higher than 50.79% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +75.26%
    MNPR shares outstanding is up +75.26% year-on-year

    Shares Outstanding 3-Year Change

    +142.42%
    MNPR shares outstanding is up +142.42% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.83
    MNPR beta is 1.83

    200-day SMA

    $33.81
    MNPR price is currently -5.19% below its 200-day simple moving average

    50-day SMA

    $37.86
    MNPR price is currently -15.33% below its 50-day simple moving average

    RSI

    37.84
    MNPR 14-day relative strength index is 37.84

    Volume

    2.12
    MNPR 30-day relative volume is 2.12

    ATR

    $3.06
    MNPR average true range is $3.06

    10-day Historical Volatility

    109.70%
    MNPR 10-day historical volatility is 109.70%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    MNPR annual revenue is $0.00

    Revenue Analysts estimate

    -
    MNPR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    MNPR annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.65%
    MNPR annual revenue is higher than 28.65% of companies in Healthcare sector

    EPS

    EPS

    -$4.11
    MNPR annual earnings per share is -$4.11

    EPS Analysts estimate

    -$1.87
    MNPR annual earnings per share is currently +119.55% higher than the consensus analysts' forecast

    EPS 1-year change

    -34.75%
    MNPR annual earnings per share is down -34.75% year-on-year

    EPS Sector rank

    21.96%
    MNPR annual earnings per share is higher than 21.96% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    MNPR annual gross profit is $0.00

    Gross margin

    -
    MNPR annual gross profit margin value is unknown

    Operating profit

    -$16.16M
    MNPR annual operating income is -$16.16 million

    Operating margin

    -
    MNPR annual operating profit margin value is unknown

    Net income

    -$15.59M
    MNPR annual net profit is -$15.59 million

    Net margin

    -
    MNPR annual net profit margin value is unknown

    Expenses

    Total expenses

    $15.59M
    MNPR annual total expenses is $15.59 million

    Operating expenses

    $16.16M
    MNPR annual total operating expenses is $16.16 million

    Cost of goods sold

    $0.00
    MNPR annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $0.00
    MNPR annual SGA is $0.00

    Depreciation and amortization

    -
    MNPR annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    MNPR annual interest expense is $0.00

    Income tax

    $0.00
    MNPR annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$16.16M
    MNPR annual earnings before interest & taxes is -$16.16 million

    EBITDA

    -$16.16M
    MNPR annual EBITDA is -$16.16 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $60.29M
    MNPR annual total assets is $60.29 million

    Non current assets

    $0.00
    MNPR annual long term assets is $0.00

    Current assets

    $60.29M
    MNPR annual total current assets is $60.29 million

    Cash and cash equivalents

    $60.21M
    MNPR annual cash & cash equivalents is $60.21 million

    Accounts receivable

    -
    MNPR annual accounts receivable value is unknown

    Inventory

    $0.00
    MNPR annual inventory is $0.00

    Liabilities

    Total liabilities

    $5.25M
    MNPR annual total liabilities is $5.25 million

    Long term liabilities

    $0.00
    MNPR annual total long term liabilities is $0.00

    Current liabilities

    $5.25M
    MNPR annual total current liabilities is $5.25 million

    Accounts payable

    $2.25M
    MNPR annual accounts payable is $2.25 million

    Debt

    Total debt

    $0.00
    MNPR annual total debt is $0.00

    Total debt 1-year change

    0%
    MNPR annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    MNPR annual long term debt is $0.00

    Short term debt

    $0.00
    MNPR annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $55.04M
    MNPR annual stockholders equity is $55.04 million

    Book value

    $55.04M
    MNPR annual book value is $55.04 million

    Retained earnings

    -$75.79M
    MNPR annual retained earnings is -$75.79 million

    Working capital

    $55.04M
    MNPR annual working capital is $55.04 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$6.40M
    MNPR annual cash flow from operations is -$6.40 million

    Cash from operations 1-year change

    +18.51%
    MNPR annual cash flow from operations is up +18.51% year-on-year

    Cash from investing

    -$14.34M
    MNPR annual cash flow from investing activities is -$14.34 million

    Cash from investing 1-year change

    -390.98%
    MNPR annual cash flow from investing activities is down -390.98% year-on-year

    Cash from financing

    $59.29M
    MNPR annual cash flow from financing activities is $59.29 million

    Cash from financing 1-year change

    +2824.84%
    MNPR annual cash flow from financing activities is up +2824.84% year-on-year

    CAPEX

    CAPEX

    $0.00
    MNPR annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    MNPR annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$6.40M
    MNPR annual free cash flow is -$6.40 million

    Free cash flow 1-year change

    +18.51%
    MNPR annual free cash flow is up +18.51% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    MNPR annual gross profit margin value is unknown

    Operating margin

    -
    MNPR annual operating profit margin value is unknown

    Net margin

    -
    MNPR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -46.09%
    MNPR annual return on assets is -46.09%

    ROE

    -51.42%
    MNPR annual return on equity is -51.42%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MNPR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MNPR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.79
    MNPR price to book ratio is 3.79

    PB ratio Sector rank

    71.62%
    MNPR price to book ratio is higher than 71.62% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    MNPR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    MNPR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $144.67M
    MNPR enterprise value is $144.67 million

    Enterprise value Sector rank

    51.13%
    MNPR enterprise value is higher than 51.13% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.57
    MNPR EV/EBITDA is -7.57

    EV/EBITDA Sector rank

    16.13%
    MNPR EV/EBITDA is higher than 16.13% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    11.47
    MNPR annual current ratio is 11.47

    Quick ratio

    11.47
    MNPR annual quick ratio is 11.47

    Leverage

    Debt to equity

    0.00
    MNPR annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    MNPR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    MNPR piotroski f-score value is unknown

    Altman Z-Score

    21.04
    MNPR altman z-score is 21.04

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 Chardan Capital
    Buy
    Jul 7, 25 Cantor Fitzgerald
    Overweight
    Apr 2, 25 Jones Trading
    Hold
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Jan 22, 25 HC Wainwright & Co.
    Buy
    Jan 10, 25 Piper Sandler
    Overweight
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Aug 14, 24 HC Wainwright & Co.
    Buy
    May 10, 24 HC Wainwright & Co.
    Buy
    Apr 11, 24 JonesTrading
    Buy

    Institutional Ownership

    Screeners with MNPR included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Best performing stocks last 5 years
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    • What is the ticker symbol for Monopar Therapeutics Inc.?
    • Does Monopar Therapeutics Inc. pay dividends?
    • What sector is Monopar Therapeutics Inc. in?
    • What industry is Monopar Therapeutics Inc. in?
    • What country is Monopar Therapeutics Inc. based in?
    • When did Monopar Therapeutics Inc. go public?
    • Is Monopar Therapeutics Inc. in the S&P 500?
    • Is Monopar Therapeutics Inc. in the NASDAQ 100?
    • Is Monopar Therapeutics Inc. in the Dow Jones?
    • When was Monopar Therapeutics Inc.'s last earnings report?
    • When does Monopar Therapeutics Inc. report earnings?

    What is the ticker symbol for Monopar Therapeutics Inc.?

    The ticker symbol for Monopar Therapeutics Inc. is NASDAQ:MNPR

    Does Monopar Therapeutics Inc. pay dividends?

    No, Monopar Therapeutics Inc. does not pay dividends

    What sector is Monopar Therapeutics Inc. in?

    Monopar Therapeutics Inc. is in the Healthcare sector

    What industry is Monopar Therapeutics Inc. in?

    Monopar Therapeutics Inc. is in the Biotechnology industry

    What country is Monopar Therapeutics Inc. based in?

    Monopar Therapeutics Inc. is headquartered in United States

    When did Monopar Therapeutics Inc. go public?

    Monopar Therapeutics Inc.'s initial public offering (IPO) was on December 19, 2019

    Is Monopar Therapeutics Inc. in the S&P 500?

    No, Monopar Therapeutics Inc. is not included in the S&P 500 index

    Is Monopar Therapeutics Inc. in the NASDAQ 100?

    No, Monopar Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Monopar Therapeutics Inc. in the Dow Jones?

    No, Monopar Therapeutics Inc. is not included in the Dow Jones index

    When was Monopar Therapeutics Inc.'s last earnings report?

    Monopar Therapeutics Inc.'s most recent earnings report was on August 12, 2025

    When does Monopar Therapeutics Inc. report earnings?

    The next expected earnings date for Monopar Therapeutics Inc. is November 7, 2025
    On this page